Antibody-dependent enhancement occurs when the antibodies the viruses bind to on the host cell permit increased entry and replication of the virus. This process has been observed in: yellow fever, zika virus, and the novel coronavirus. ADE affects vaccine development by being a possible unforeseen phenomenon that could cause the vaccine to worsen the patient's condition rather than providing an inflammatory response.